Logo image of ORIS

ORIENTAL RISE HOLDINGS LTD (ORIS) Stock Fundamental Analysis

NASDAQ:ORIS - KYG6781A1022 - Common Stock

0.1151 USD
+0.01 (+4.64%)
Last: 8/28/2025, 2:55:43 PM
Fundamental Rating

4

Overall ORIS gets a fundamental rating of 4 out of 10. We evaluated ORIS against 90 industry peers in the Food Products industry. ORIS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ORIS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ORIS was profitable.
ORIS had a positive operating cash flow in the past year.
ORIS Yearly Net Income VS EBIT VS OCF VS FCFORIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2M 4M 6M 8M 10M

1.2 Ratios

With a decent Return On Assets value of 5.93%, ORIS is doing good in the industry, outperforming 77.78% of the companies in the same industry.
ORIS's Return On Equity of 6.10% is in line compared to the rest of the industry. ORIS outperforms 55.56% of its industry peers.
The Return On Invested Capital of ORIS (4.78%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ORIS is significantly below the industry average of 27.81%.
The 3 year average ROIC (11.00%) for ORIS is well above the current ROIC(4.78%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROIC 4.78%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ORIS Yearly ROA, ROE, ROICORIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of ORIS (18.84%) is better than 96.67% of its industry peers.
In the last couple of years the Profit Margin of ORIS has declined.
ORIS has a Operating Margin of 18.73%. This is amongst the best in the industry. ORIS outperforms 93.33% of its industry peers.
In the last couple of years the Operating Margin of ORIS has declined.
ORIS has a Gross Margin of 29.04%. This is in the better half of the industry: ORIS outperforms 63.33% of its industry peers.
In the last couple of years the Gross Margin of ORIS has declined.
Industry RankSector Rank
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
ORIS Yearly Profit, Operating, Gross MarginsORIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

ORIS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ORIS has been increased compared to 1 year ago.
There is no outstanding debt for ORIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ORIS Yearly Shares OutstandingORIS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORIS Yearly Total Debt VS Total AssetsORIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.21 indicates that ORIS is not in any danger for bankruptcy at the moment.
ORIS's Altman-Z score of 3.21 is fine compared to the rest of the industry. ORIS outperforms 67.78% of its industry peers.
There is no outstanding debt for ORIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.21
ROIC/WACC0.62
WACC7.72%
ORIS Yearly LT Debt VS Equity VS FCFORIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 20M 40M 60M

2.3 Liquidity

ORIS has a Current Ratio of 24.80. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ORIS (24.80) is better than 100.00% of its industry peers.
ORIS has a Quick Ratio of 23.79. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ORIS (23.79) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 24.8
Quick Ratio 23.79
ORIS Yearly Current Assets VS Current LiabilitesORIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

ORIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.76%.
ORIS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.95% yearly.
Looking at the last year, ORIS shows a very negative growth in Revenue. The Revenue has decreased by -42.06% in the last year.
The Revenue for ORIS have been decreasing by -12.44% on average. This is quite bad
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ORIS Yearly Revenue VS EstimatesORIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.43, the valuation of ORIS can be described as very cheap.
ORIS's Price/Earnings ratio is rather cheap when compared to the industry. ORIS is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ORIS to the average of the S&P500 Index (27.14), we can say ORIS is valued rather cheaply.
Industry RankSector Rank
PE 0.43
Fwd PE N/A
ORIS Price Earnings VS Forward Price EarningsORIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ORIS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ORIS is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.85
EV/EBITDA -7.57
ORIS Per share dataORIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ORIS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORIENTAL RISE HOLDINGS LTD

NASDAQ:ORIS (8/28/2025, 2:55:43 PM)

0.1151

+0.01 (+4.64%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins Owners73.82%
Ins Owner ChangeN/A
Market Cap2.53M
AnalystsN/A
Price TargetN/A
Short Float %86.49%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.43
Fwd PE N/A
P/S 0.11
P/FCF 0.85
P/OCF 0.78
P/B 0.04
P/tB 0.04
EV/EBITDA -7.57
EPS(TTM)0.27
EY234.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY117.55%
OCF(TTM)0.15
OCFY127.74%
SpS1.03
BVpS3.19
TBVpS3.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROCE 6.05%
ROIC 4.78%
ROICexc 12.32%
ROICexgc 12.32%
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
FCFM 13.11%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ROICexc(3y)22.86%
ROICexc(5y)N/A
ROICexgc(3y)22.86%
ROICexgc(5y)N/A
ROCE(3y)14.51%
ROCE(5y)N/A
ROICexcg growth 3Y-34.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-34.59%
ROICexc growth 5YN/A
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 23.29%
Cap/Sales 1.14%
Interest Coverage 31.04
Cash Conversion 60.36%
Profit Quality 69.6%
Current Ratio 24.8
Quick Ratio 23.79
Altman-Z 3.21
F-Score4
WACC7.72%
ROIC/WACC0.62
Cap/Depr(3y)60.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.01%
Cap/Sales(5y)N/A
Profit Quality(3y)117.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.57%
EBIT growth 3Y-39.69%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.61%
FCF growth 3Y71.83%
FCF growth 5YN/A
OCF growth 1Y-74.39%
OCF growth 3Y-28.66%
OCF growth 5YN/A